Found 32 matching trials
Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission
PHASE2The primary aim of this innovative immunotherapeutic study is to determine ...
Status
Active Not Recruiting
Ovarian Dendritic Cell Vaccine Trial
PHASE2The purpose of this study is to determine if a dendritic cell vaccine made ...
Location
Loyola Univeristy Medical Center, Cardinal Bernardin Cancer Center
Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia
NAThe primary aim of this innovative immunotherapy using WT1/hTERT/Survivin-l...
Location
Department of hematology
Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome
PHASE1This study will test whether certain patients with myelodysplastic syndrome...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
PHASE1This is a multicenter, open label, Phase 1 dose-escalation study of DSP-788...
Location
USOR - Rocky Mountain Cancer Center
Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission
PHASE1This randomized phase I trial studies the side effects and best way to give...
Location
University of Chicago
A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
PHASE3This is an event driven, adaptive design, a randomized, active-controlled, ...
Location
University of Alabama at Birmingham
WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)
PHASE2This trial will assess the safety and efficacy of vaccination with galinpep...
Location
Memorial Sloan Kettering Cancer Center
Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers
PHASE2This study will test the safety and effectiveness of two vaccines on slowin...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Dendritic Cell Vaccination for Patients With Acute Myeloid Leukemia in Remission
PHASE1RATIONALE: Vaccines made from a patient's white blood cells (dendritic cell...
Location
Antwerp University Hospital/Center for Cellular Therapy and Regenerative Medicine